Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2015, Article ID 784954, 8 pages
http://dx.doi.org/10.1155/2015/784954
Research Article

Retinal Targets ALDH Positive Cancer Stem Cell and Alters the Phenotype of Highly Metastatic Osteosarcoma Cells

1Department of Orthopaedic Surgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
2Cancer Stem Cell Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA 15219, Kazakhstan
3Laboratory of Cellular Technology, Nazarbayev University, Astana, Akmola 010000, USA

Received 12 October 2015; Accepted 17 November 2015

Academic Editor: Kanya Honoki

Copyright © 2015 Xiaodong Mu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-H. Tang and L. J. Gudas, “Retinoids, retinoic acid receptors, and cancer,” Annual Review of Pathology, vol. 6, pp. 345–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Noy, “Between death and survival: retinoic acid in regulation of apoptosis,” Annual Review of Nutrition, vol. 30, pp. 201–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Schenk, S. Stengel, and A. Zelent, “Unlocking the potential of retinoic acid in anticancer therapy,” British Journal of Cancer, vol. 111, pp. 2039–2045, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-C. Chen, C.-Y. Huang, S.-L. Hsu et al., “Retinoic acid induces apoptosis of prostate cancer DU145 cells through Cdk5 overactivation,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 580736, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. Huss, L. Lai, R. J. Barrios, K. K. Hirschi, and N. M. Greenberg, “Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer,” The Prostate, vol. 61, no. 2, pp. 142–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Ginestier, J. Wicinski, N. Cervera et al., “Retinoid signaling regulates breast cancer stem cell differentiation,” Cell Cycle, vol. 8, no. 20, pp. 3297–3302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Huang, Y. C. Ye, S. R. Chen et al., “Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia,” Blood, vol. 72, no. 2, pp. 567–572, 1988. View at Google Scholar
  8. U. C. Dräger, E. Wagner, and P. McCaffery, “Aldehyde dehydrogenases in the generation of retinoic acid in the developing vertebrate: a central role of the eye,” The Journal of Nutrition, vol. 128, supplement 2, pp. 463S–466S, 1998. View at Google Scholar · View at Scopus
  9. D. Raha, T. R. Wilson, J. Peng et al., “The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation,” Cancer Research, vol. 74, no. 13, pp. 3579–3590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Marcato, C. A. Dean, C. A. Giacomantonio, and P. W. K. Lee, “Aldehyde dehydrogenase its role as a cancer stem cell marker comes down to the specific isoform,” Cell Cycle, vol. 10, no. 9, pp. 1378–1384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Charafe-Jauffret, C. Ginestier, F. Iovino et al., “Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer,” Clinical Cancer Research, vol. 16, no. 1, pp. 45–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Deng, X. Yang, H. Lassus et al., “Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers,” PLoS ONE, vol. 5, no. 4, Article ID e10277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Honoki, H. Fujii, A. Kubo et al., “Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance,” Oncology Reports, vol. 24, no. 2, pp. 501–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Feng, Q. Qi, A. Khanna et al., “Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer,” Molecular Cancer Research, vol. 7, no. 3, pp. 330–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Zhou, Y.-D. Mu, J. Liang et al., “Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma,” Molecular Medicine Reports, vol. 11, no. 5, pp. 3894–3899, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Li, F. Ma, H. Wang et al., “Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer,” The International Journal of Biological Markers, vol. 28, no. 4, pp. e357–e364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Mu, C. Isaac, N. Greco, J. Huard, and K. Weiss, “Notch signaling is associated with ALDH activity and an aggressive metastatic phenotype in murine osteosarcoma cells,” Frontiers in Oncology, vol. 3, article 143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Mu, C. Isaac, T. Schott, J. Huard, and K. Weiss, “Rapamycin inhibits ALDH activity, resistance to oxidative stress, and metastatic potential in murine osteosarcoma cells,” Sarcoma, vol. 2013, Article ID 480713, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Mu, D. Brynien, and K. R. Weiss, “The HDAC inhibitor vorinostat diminishes the in vitro metastatic behavior of osteosarcoma cells,” BioMed Research International, vol. 2015, Article ID 290368, 6 pages, 2015. View at Publisher · View at Google Scholar
  20. X. Mu, B. Sultankulov, R. Agarwal et al., “Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells,” Clinical Orthopaedics and Related Research, vol. 472, no. 3, pp. 865–873, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Greco, T. Schott, X. Mu et al., “ALDH activity correlates with metastatic potential in primary sarcomas of bone,” Journal of Cancer Therapy, vol. 5, no. 4, pp. 331–338, 2014. View at Publisher · View at Google Scholar